Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings - Zacks Investment Research
Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings - Zacks Investment Research（摘要待生成）
IDXX Apr 2027 530.000 put (IDXX270416P00530000) interactive stock chart – Yahoo Finance
IDXX Apr 2027 530.000 put (IDXX270416P00530000) interactive stock chart Yahoo Finance UK
Jefferies downgraded Zoetis and Elanco, citing animal-health pricing risks; reiterated Buy on IDEXX
On October 20, Jefferies cut Zoetis and Elanco to Hold from Buy, citing pricing risk, muted vet visits, mid-single-digit vet-labor inflation and waning owner sentiment; it said price and mix account for all growth in vet and pet services, versus 50%–65% pre-pandemic. Jefferies reiterated Buy on IDEXX. ([uk.investing.com](https://uk.investing.com/news/stock-market-news/jefferies-downgrades-zoetis-e
Jefferies cuts IDEXX target to $705 from $795; contrasts with Zoetis and Elanco cuts
On Oct. 20, 2026, Jefferies reiterated Buy on IDEXX and cut its target to $705 from $795. The same day, analyst Keith Devas downgraded Zoetis and Elanco to Hold from Buy, cutting targets to $83 from $103 and $24 from $31, respectively; he cited veterinary-sector pricing-power risks.
BTIG Suspends Buy Rating on IDEXX Laboratories
BTIG Suspends Buy Rating on IDEXX Laboratories（摘要待生成）
IDEXX court case: default set aside in former employee’s disability-discrimination action
On October 16, the U.S. District Court for the District of Maryland issued an order in Lovey McClain v. IDEXX Laboratories, a disability-discrimination action against the company. The order concerns procedural motions; the available page does not state a damages amount.